Principal Financial Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-17,236
| Closed | -$905K | – | 2503 |
|
|
2020
Q3 | $905K | Sell |
17,236
-906,732
| -98% | -$37.5M | ﹤0.01% | 1891 |
|
|
2020
Q2 | $30.7M | Buy |
923,968
+32,724
| +4% | +$1.04M | 0.03% | 492 |
|
|
2020
Q1 | $24.2M | Sell |
891,244
-32,673
| -4% | -$910K | 0.03% | 484 |
|
|
2019
Q4 | $18.2M | Buy |
923,917
+115,205
| +14% | +$1.84M | 0.02% | 871 |
|
|
2019
Q3 | $10.5M | Sell |
808,712
-9,628
| -1% | -$116K | 0.01% | 1184 |
|
|
2019
Q2 | $10.2M | Sell |
818,340
-12,243
| -1% | -$163K | 0.01% | 1211 |
|
|
2019
Q1 | $12.1M | Buy |
830,583
+13,591
| +2% | +$174K | 0.01% | 1122 |
|
|
2018
Q4 | $9.02M | Buy |
816,992
+138,034
| +20% | +$1.92M | 0.01% | 1232 |
|
|
2018
Q3 | $17.9M | Buy |
678,958
+31,964
| +5% | +$864K | 0.02% | 935 |
|
|
2018
Q2 | $13.2M | Buy |
646,994
+8,162
| +1% | +$175K | 0.01% | 1117 |
|
|
2018
Q1 | $11.6M | Buy |
638,832
+21,142
| +3% | +$352K | 0.01% | 1170 |
|
|
2017
Q4 | $8.62M | Buy |
617,690
+10,990
| +2% | +$149K | 0.01% | 1344 |
|
|
2017
Q3 | $11.2M | Buy |
606,700
+65,014
| +12% | +$1.09M | 0.01% | 1167 |
|
|
2017
Q2 | $9.15M | Buy |
541,686
+25,144
| +5% | +$383K | 0.01% | 1278 |
|
|
2017
Q1 | $6.9M | Buy |
516,542
+21,872
| +4% | +$343K | 0.01% | 1408 |
|
|
2016
Q4 | $7.45M | Buy |
494,670
+24,804
| +5% | +$328K | 0.01% | 1358 |
|
|
2016
Q3 | $5.49M | Buy |
469,866
+13,641
| +3% | +$160K | 0.01% | 1428 |
|
|
2016
Q2 | $4.93M | Buy |
456,225
+20,278
| +5% | +$209K | 0.01% | 1435 |
|
|
2016
Q1 | $4.03M | Buy |
435,947
+12,789
| +3% | +$138K | 0.01% | 1461 |
|
|
2015
Q4 | $6.28M | Buy |
423,158
+18,504
| +5% | +$310K | 0.01% | 1244 |
|
|
2015
Q3 | $6.64M | Buy |
404,654
+31,903
| +9% | +$653K | 0.01% | 1189 |
|
|
2015
Q2 | $8.5M | Buy |
372,751
+73,001
| +24% | +$1.45M | 0.01% | 1105 |
|
|
2015
Q1 | $4.56M | Buy |
299,750
+16,964
| +6% | +$220K | 0.01% | 1412 |
|
|
2014
Q4 | $3.4M | Buy |
282,786
+3,158
| +1% | +$36.1K | 0.01% | 1548 |
|
|
2014
Q3 | $3.17M | Sell |
279,628
-18,680
| -6% | -$213K | 0.01% | 1532 |
|
|
2014
Q2 | $3.6M | Sell |
298,308
-4,819
| -2% | -$56.9K | 0.01% | 1540 |
|
|
2014
Q1 | $3.53M | Buy |
303,127
+23,553
| +8% | +$399K | 0.01% | 1522 |
|
|
2013
Q4 | $4.94M | Buy |
279,574
+8,812
| +3% | +$148K | 0.01% | 1352 |
|
|
2013
Q3 | $3.9M | Buy |
270,762
+29,537
| +12% | +$452K | 0.01% | 1424 |
|
|
2013
Q2 | $3.63M | Buy |
+241,225
| New | +$3.18M | 0.01% | 1381 |
|
Principal Financial Group's MNTA Position: Q4 2020 in Review
Principal Financial Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 17,236 shares — an estimated $905K sold.
Principal Financial Group first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $30.7M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Principal Financial Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Principal Financial Group sold 17,236 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $905K.
- Principal Financial Group first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Principal Financial Group's Momenta Pharmaceuticals, Inc. position peaked at $30.7M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Principal Financial Group's 13F filing for Q4 2020, filed 8 Feb 2021.